B. Riley Wealth Advisors Inc. lowered its holdings in The Allstate Co. (NYSE:ALL – Free Report) by 9.1% in the third quarter, Holdings Channel reports. The firm owned 3,131 shares of the insurance provider’s stock after selling 314 shares during the quarter. B. Riley Wealth Advisors Inc.’s holdings in Allstate were worth $593,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ALL. Pathway Financial Advisers LLC boosted its stake in shares of Allstate by 18,472.5% during the 3rd quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider’s stock worth $199,642,000 after buying an additional 1,047,019 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its position in Allstate by 18.7% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider’s stock valued at $569,114,000 after purchasing an additional 472,040 shares during the last quarter. AQR Capital Management LLC grew its stake in Allstate by 181.6% in the second quarter. AQR Capital Management LLC now owns 719,997 shares of the insurance provider’s stock valued at $114,955,000 after purchasing an additional 464,337 shares in the last quarter. TimesSquare Capital Management LLC acquired a new position in shares of Allstate during the 3rd quarter worth approximately $77,819,000. Finally, Acadian Asset Management LLC raised its stake in shares of Allstate by 3,839.0% during the 2nd quarter. Acadian Asset Management LLC now owns 416,117 shares of the insurance provider’s stock worth $66,417,000 after purchasing an additional 405,553 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Allstate Trading Down 2.1 %
Shares of Allstate stock opened at $189.25 on Thursday. The Allstate Co. has a 52-week low of $134.17 and a 52-week high of $209.88. The stock has a market cap of $50.11 billion, a PE ratio of 12.26, a PEG ratio of 1.70 and a beta of 0.50. The firm has a 50-day moving average of $195.53 and a 200-day moving average of $181.99. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40.
Allstate Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th will be issued a $0.92 dividend. The ex-dividend date is Friday, November 29th. This represents a $3.68 annualized dividend and a yield of 1.94%. Allstate’s dividend payout ratio is presently 23.83%.
Insider Activity
In related news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now owns 27,364 shares of the company’s stock, valued at $5,236,922.32. The trade was a 57.06 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.80% of the company’s stock.
Analysts Set New Price Targets
Several equities analysts recently weighed in on the stock. Raymond James raised their target price on shares of Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research note on Friday, October 4th. UBS Group boosted their price objective on shares of Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. Jefferies Financial Group upped their target price on shares of Allstate from $231.00 to $267.00 and gave the company a “buy” rating in a report on Friday, November 8th. JPMorgan Chase & Co. lifted their price target on Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a report on Thursday, October 10th. Finally, StockNews.com lowered Allstate from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 21st. One research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $217.19.
View Our Latest Stock Report on ALL
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Further Reading
- Five stocks we like better than Allstate
- How to Capture the Benefits of Dividend Increases
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Top Biotech Stocks: Exploring Innovation Opportunities
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- The 3 Best Blue-Chip Stocks to Buy Now
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.